Answers are grounded in this paper and cite their sources.
Letters to the Editor been implicated in the past, but symptoms appeared approximately four weeks after the last dose of gentamicin.It is possible that one or more of the previously administered cytotoxics may have been responsible but this has not been reported before, and the last course of treatment was eight weeks before the onset of her neurological symptoms.A further possibility is that our patient developed OM as a direct manifes- tation of Hodgkin's disease, but at the time of development of OM the extent of her disease had considerably reduced following high dose chemotherapy.Furthermore, before the onset of neurological symptoms she had had clinical and radiological evi- dence of regression of her disease.Normal CT and MRI scans of her brain excludes a diagnosis of cerebral Hodgkin's disease.A metabolic abnormality resulting from destruction of Hodgkin's disease tissue is also unlikely, although it has been previously postulated that production of neuro- toxic amines and/or peptides might be responsible.9This report, however, failed to show any correlation between the presence or severity of OM and the routinely avail- able measurements of catecholamine secre- tion.The discovery of antineuronal antibodies in patients with other paraneoplastic syndromes has led to the suggestion that these diseases may have an autoim- mune aetiology.Support for an autoim- mune basis to paraneoplastic OM has come from reports of a specific antineuronal autoantibody (anti-Ri) in the serum of patients with opsoclonus and breast carci- noma.'0The presence of the Ri antigen in tumour tissue of these patients suggests that it is the body's immune response to a tumour antigen that elicits the antibody response.Although there was no specific autoimmune serological data to support such a response in our patient, it is possible that breakdown of lymphomatous tissue resulting from effective chemotherapy led to the production of antineuronal antibodies and the subsequent development of OM.Treatment for opsoclonus from whatever cause remains uncertain.While some authors recommend ACTH or steroids,4 this is by no means of proven benefit.At the very least, it is imperative to treat the underlying condition.
No takes yet. Share an insight, caveat, or question.
Doyu et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: